While CVS Health Corp has overperformed by 1.38%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CVS rose by 76.25%, with highs and lows ranging from $85.15 to $43.65, whereas the simple moving average jumped by 12.10% in the last 200 days.
On October 14, 2025, Goldman started tracking CVS Health Corp (NYSE: CVS) recommending Buy. A report published by UBS on August 18, 2025, Upgraded its rating to ‘Buy’ for CVS. Robert W. Baird also Upgraded CVS shares as ‘Outperform’, setting a target price of $82 on the company’s shares in a report dated August 14, 2025. Leerink Partners February 13, 2025d the rating to Outperform on February 13, 2025, and set its price target from $55 to $75. Cantor Fitzgerald February 12, 2025d its ‘Neutral’ rating to ‘Overweight’ for CVS, as published in its report on February 12, 2025. Deutsche Bank also rated the stock as ‘Buy’.
Analysis of CVS Health Corp (CVS)
It’s important to note that CVS shareholders are currently getting $2.66 per share in dividends, so investors will receive a return regardless of how the company performs. Further, the quarter-over-quarter increase in sales is 7.83%, showing a positive trend in the upcoming months.
CVS Health Corp’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of 0.63% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.63, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and CVS is registering an average volume of 7.50M. On a monthly basis, the volatility of the stock is set at 2.25%, whereas on a weekly basis, it is put at 1.50%, with a gain of 1.59% over the past seven days. Furthermore, long-term investors anticipate a median target price of $94.71, showing growth from the present price of $79.12, which can serve as yet another indication of whether CVS is worth investing in or should be passed over.
How Do You Analyze CVS Health Corp Shares?
A giant in the Healthcare Plans market, CVS Health Corp (CVS) is based in the USA. When comparing CVS Health Corp shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 206.74, there is a growth in quarterly earnings of -4633.14%.
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.15%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 89.03% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
